
Line
|

Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
9.130
Open
8.920
VWAP
9.03
Vol
22.63K
Mkt Cap
247.84M
Low
8.870
Amount
204.34K
EV/EBITDA(TTM)
12.10
Total Shares
27.29M
EV
390.25M
EV/OCF(TTM)
15.45
P/S(TTM)
0.54
ZimVie Inc. is a global life sciences company in the dental market. The Company develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. The Company works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including dental implants, biomaterials, and digital workflow solutions. In the dental segment, its core services include designing, manufacturing and distributing dental implant systems. The key products in its dental implant systems portfolio include the T3 Implant, Tapered Screw-Vent Implant System, Trabecular Metal Dental Implant, BellaTek Encode Impression System, and Puros Allograft Particulate. The Company markets its products in about 70 countries in North America, Europe, Latin America and Asia.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q3
FY2025Q2
FY2025Q1
105.25M
+1.96%
0.174
+44.66%
116.48M
-0.28%
0.230
+77.04%
113.41M
-4.05%
0.222
+177.05%
Estimates Revision
The market is revising Downward the revenue expectations for ZimVie Inc. (ZIMV) for FY2025, with the revenue forecasts being adjusted by -1.67% over the past three months. During the same period, the stock price has changed by -31.61%.
Revenue Estimates for FY2025
Revise Downward

-1.67%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward

+10.89%
In Past 3 Month
Stock Price
Go Down

-31.61%
In Past 3 Month
2 Analyst Rating

75.25% Upside
Wall Street analysts forecast ZIMV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ZIMV is 16.00 USD with a low forecast of 16.00 USD and a high forecast of 16.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
1 Hold
0 Sell
Moderate Buy

75.25% Upside
Current: 9.130

Low
16.00
Averages
16.00
High
16.00

75.25% Upside
Current: 9.130

Low
16.00
Averages
16.00
High
16.00
Needham
David Saxon
Hold
Reiterates
n/a
2025-04-09
Reason
Needham
David Saxon
Price Target
n/a
2025-04-09
Reiterates
Hold
Reason
Needham
David Saxon
Strong Buy
to
Hold
Downgrades
n/a
2025-03-13
Reason
Needham
David Saxon
Price Target
n/a
2025-03-13
Downgrades
Strong Buy
to
Hold
Reason
Needham downgraded ZimVie to Hold from Buy without a price target. With a debate around whether the dental market's long-term growth profile has shifted lower and recent indicators pointing to weakening U.S. consumer sentiment, Needham does not expect dental market growth to improve in the near-term, the analyst tells investors in a research note. The firm says that with Dentsply and ZimVie both seeing below-market growth and no meaningful upside catalyst to drive near-term multiple expansion, it no longer believes the stocks can outperform relative to its broader coverage.
Needham
David Saxon
Strong Buy
Reiterates
$23
2025-02-27
Reason
Needham
David Saxon
Price Target
$23
2025-02-27
Reiterates
Strong Buy
Reason
Needham
David Saxon
Strong Buy
Maintains
$20 → $23
2024-08-02
Reason
Needham
David Saxon
Price Target
$20 → $23
2024-08-02
Maintains
Strong Buy
Reason
Needham
David Saxon
Strong Buy
Reiterates
$20
2024-06-25
Reason
Needham
David Saxon
Price Target
$20
2024-06-25
Reiterates
Strong Buy
Reason
Needham
David Saxon
Hold
to
Strong Buy
Upgrades
n/a
2024-05-16
Reason
Needham
David Saxon
Price Target
n/a
2024-05-16
Upgrades
Hold
to
Strong Buy
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for ZimVie Inc (ZIMV.O) is 10.23, compared to its 5-year average forward P/E of 17.16. For a more detailed relative valuation and DCF analysis to assess ZimVie Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Fair
5Y Average PE
17.16
Current PE
10.23
Overvalued PE
24.58
Undervalued PE
9.74
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Fair
5Y Average EV/EBITDA
8.26
Current EV/EBITDA
5.93
Overvalued EV/EBITDA
11.72
Undervalued EV/EBITDA
4.80
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair
5Y Average PS
0.61
Current PS
0.55
Overvalued PS
0.92
Undervalued PS
0.30
Financials
Annual
Quarterly
FY2024Q4
YoY :
-1.37%
111.52M
Total Revenue
FY2024Q4
YoY :
-130.04%
1.64M
Operating Profit
FY2024Q4
YoY :
-97.11%
-9.67M
Net Income after Tax
FY2024Q4
YoY :
-96.58%
-0.43
EPS - Diluted
FY2024Q4
YoY :
-60.25%
7.41M
Free Cash Flow
FY2024Q4
YoY :
+5.27%
59.92
Gross Profit Margin - %
FY2024Q4
YoY :
-23.38%
4.13
FCF Margin - %
FY2024Q4
YoY :
-55.77%
-8.67
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
525.0K
Volume
1
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
5
700.0K
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
ZIMV News & Events
Events Timeline
2025-04-21 (ET)
2025-04-21
08:04:06
ZimVie announces launch of its Immediate Molar Implant system in US

2025-02-26 (ET)
2025-02-26
16:31:18
ZimVie sees FY25 adjusted EPS 80c-95c, consensus 75c

2025-02-26
16:29:57
ZimVie reports Q4 adjusted EPS 27c, consensus 26c

Sign Up For More Events
Sign Up For More Events
News
4.0
04-09Business InsiderZimVie initiated with a Buy at B. Riley
1.0
03-25NewsfilterZimVie to Participate in the 24th Annual Needham Virtual Healthcare Conference
4.0
03-13BenzingaDental Players Dentsply Sirona, ZimVie Show Weak Growth Outlook: Analyst
Sign Up For More News
People Also Watch

CMPS
Compass Pathways PLC
3.785
USD
+1.20%

CVEO
Civeo Corp
20.010
USD
+3.68%

MTW
Manitowoc Company Inc
9.500
USD
+10.98%

PGEN
Precigen Inc
1.380
USD
+2.22%

BLDE
Blade Air Mobility Inc
2.940
USD
+6.14%

ASUR
Asure Software Inc
9.670
USD
0.00%

LPA
Logistic Properties of The Americas
6.050
USD
-1.14%

ACRE
Ares Commercial Real Estate Corp
4.805
USD
+2.67%

VACH
Voyager Acquisition Corp
10.275
USD
0.00%

OB
Outbrain Inc
3.480
USD
+3.26%
FAQ

What is ZimVie Inc (ZIMV) stock price today?
The current price of ZIMV is 9.13 USD — it has increased 2.58 % in the last trading day.

What is ZimVie Inc (ZIMV)'s business?

What is the price predicton of ZIMV Stock?

What is ZimVie Inc (ZIMV)'s revenue for the last quarter?

What is ZimVie Inc (ZIMV)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for ZimVie Inc (ZIMV)'s fundamentals?

How many employees does ZimVie Inc (ZIMV). have?
